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The frequency of antifungal resistance, particularly to the azole class of ergosterol biosyn-
thetic inhibitors, is a growing global health problem. Survival rates for those infected with
resistant isolates are exceptionally low. Beyond modiﬁcation of the drug target, our under-
standing of the molecular basis of azole resistance in the fungal pathogen Aspergillus fumi-
gatus is limited. We reasoned that clinically relevant antifungal resistance could derive from
transcriptional rewiring, promoting drug resistance without concomitant reductions in
pathogenicity. Here we report a genome-wide annotation of transcriptional regulators in
A. fumigatus and construction of a library of 484 transcription factor null mutants. We identify
12 regulators that have a demonstrable role in itraconazole susceptibility and show that
loss of the negative cofactor 2 complex leads to resistance, not only to the azoles but also
the salvage therapeutics amphotericin B and terbinaﬁne without signiﬁcantly affecting
pathogenicity.
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A spergillus fumigatus is the most important airbornemould pathogen and allergen worldwide. Estimates sug-gest that over 3 million people have invasive or chronic
infections that lead to in excess of 600,000 deaths every year1.
Only three classes of drugs are currently recommended for the
treatment of aspergillosis with the azole class being recommended
for primary therapeutic purposes, and amphotericin B and the
echinocandins (caspofungin and micafungin) for salvage therapy.
With effective treatment, mortality rates for invasive disease
remain ~50%2. It is of great concern, however, that drug resistance
to the azoles is rapidly emerging. For individuals that are infected
with a resistant isolate the mortality rate exceeds 80%3,4. As dis-
ease progression is so rapid in invasive aspergillosis (IA)5, therapy
failure is attributable to delays in administering alternative agents.
Methods to rapidly detect resistance are critical to ensure effective
transition to alternative appropriate therapies.
Our understanding of the factors governing azole resistance in
A. fumigatus is not fully deﬁned. The azoles act by inhibiting the
hemoprotein lanosterol demethylase (Cyp51A) resulting in a
reduction of the key sterol, ergosterol, in the fungal membrane
and an accumulation of toxic sterol intermediates6. Azole resis-
tance is frequently associated with an allelic variant of cyp51A
that incorporates a tandem repeat in the promoter, typically TR34
or TR46, with a secondary non-synonymous mutation within its
coding sequence7. These modiﬁcations appear to have no sub-
stantial impact on pathogenicity in murine models of invasive
aspergillosis8. The mechanism of resistance in a signiﬁcant pro-
portion of other isolates remains unclear7. This hinders the
development of rapid molecular diagnostics to detect drug
resistance in the clinic. Our limited understanding of the
mechanisms of azole resistance also prevents the development of
combination therapeutic strategies that speciﬁcally target drug-
resistance mechanisms9.
We and others have recently reported on the role played by
various A. fumigatus transcriptional regulators in response to
azole antifungal drugs10–12. The sterol regulatory element-
binding protein (SREBP), SrbA is a basic helix–loop–helix
(bHLH) transcriptional activator which directly regulates at least
seven genes in the ergosterol biosynthetic pathway, including
cyp51A10. Loss of srbA through gene replacement results in a
signiﬁcant increase in susceptibility to azoles13 in part due to
signiﬁcant reductions in cyp51A mRNA levels14. The binding site
for SrbA in the cyp51A promoter falls within the 34 and 46 mers
duplicated in TR34/46 pandemic azole-resistant isolates12. The
repeat duplicates the DNA-binding site leading to SrbA-mediated
upregulation of cyp51A and a concomitant increase in azole
resistance. AtrR, a Zn2-Cys6 transcription factor, also positively
regulates sterol biosynthesis and directly binds the cyp51A pro-
moter at the TR site, and additionally the promoter of an azole
exporter, cdr1B11,15. The CCAAT-binding domain complex CBC,
a heterotrimer comprising HapB, HapC and HapE, is a negative
regulator of sterol biosynthesis directly binding the promoters of
14 ergosterol biosynthetic genes, including cyp51A12. Loss of CBC
function leads to pan-azole resistance. Notably, a clinical azole-
resistant isolate with a defect in HapE that results in perturbed
DNA binding at the cyp51A promoter has been described12,16.
Binding of the CBC at the cyp51A promoter is facilitated by
another transcriptional regulator, HapX12. HapX is an iron-
responsive basic region leucine zipper (bZIP) transcription factor
that regulates the expression of genes linked to iron acquisition,
storage and metabolism and facilitates binding of the CBC17. It is
also notable that loss of SrbA, the CBC, HapX or AtrR is asso-
ciated with signiﬁcant reductions in virulence in murine models
of invasive pulmonary aspergillosis11–13,17.
The transcriptional network governing azole resistance is
therefore highly complex and involves multiple regulators, some
of which remain to be identiﬁed as our current models of this
network are not able to explain all of the existing clinically sig-
niﬁcant mechanisms of azole resistance. We therefore postulated
that other perturbations of the transcriptional network would
lead to alterations in azole resistance without affecting
pathogenicity.
In this study, we have generated and screened a library of 484
A. fumigatus transcription factor null mutant strains and iden-
tiﬁed a cohort of 12 factors that govern azole resistance and
sensitivity. Here, we describe in detail the role of two CBF/NF-Y
family transcription regulators, AFUB_029870 (NctA) and
AFUB_045980 (NctB) where loss of function leads to azole
resistance. We show that the A. fumigatus NctA and NctB
(Negative cofactor two A and B) are part of the same transcrip-
tional regulatory complex and demonstrate that the NCT com-
plex is a key regulator of ergosterol biosynthesis and the azole
exporter CDR1B. We also report that loss of the NCT complex
leads to a multi-drug-resistance phenotype, including the azoles
(itraconazole, voriconazole and posaconazole) as well as the sal-
vage therapeutic amphotericin B18 and terbinaﬁne, an agent used
in the treatment of chronic and allergic disease19. Furthermore,
loss of this complex results in a notable increase in the immu-
nogenic properties of A. fumigatus, but does not result in loss of
virulence. The results of our study highlight that loss of function
of a single gene can give rise to cross-resistance to many of the
primary drugs used to treat aspergillosis and should prompt
clinical centres to look for these mechanisms of resistance. As we
also show that strains lacking a functional NCT complex are
hypersensitive to the echinocandins, switching patients har-
bouring strains with these mutations to caspofungin could be a
preferred course of action.
Results
Generation of a library of transcription factor null mutants. A
systematic review of the genes previously annotated as tran-
scription factors (TFs) in the databases at ENSEMBL fungi,
ASPGD and DBD20 resulted in the identiﬁcation of 495 putative
TFs (Supplementary Data 1). To further characterise this cohort,
we classiﬁed each TF according to its Pfam domains, identiﬁed
using Hidden Markov Model proﬁling (hmmscan). The majority
of TFs were shown to have either one (n= 245) or two (n= 158)
functional domains associated with transcriptional regulation
(Supplementary Fig. 1). The most common domains identiﬁed
were binuclear zinc cluster (n= 192 (PFAM00172) and fungal-
speciﬁc transcription domains (n= 195 (PFAM04052 and
11951); Supplementary Fig. 1). This is consistent with previous
reports that describe domains of transcription factors in asco-
mycetes21. Sixty-two proteins lacked any Pfam domains asso-
ciated with transcription factor function. However, following
cross-referencing of these to orthologues in the AF293 genome
(whose genome annotation has been enhanced by comparison to
RNA-seq data) to reconcile annotation differences, and additional
evaluation to identify PROSITE, SUPERFAMILY, SMART and
CDD domains, we were able to identify transcription factor-
associated domains for all, but six proteins (Supplementary
Data. 1). For two of these proteins, MedA and LaeA, a functional
role in transcriptional regulation has been deﬁned experimen-
tally22–24. We were unable to identify any functional domains in
the orthologue of the TFIIIC subunit tfc6 or three proteins
annotated as RfeD, F and G.
Unlike in the model yeast, Saccharomyces cerevisiae, gene
replacement strategies in A. fumigatus are complicated by
relatively low levels of homologous recombination. This problem
can be mitigated by the use of strains lacking components of the
non-homologous end joining machinery25, such as Ku7026,
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Ku8027 and Lig428, however, even in strains lacking these factors,
gene replacement cassettes require around 1 kb of homologous
sequence ﬂanking each side of a target gene27. To facilitate the
disruption of all of the TFs identiﬁed, we chose to employ a fusion
PCR approach similar to that described by Szewczyk et al.29 (see
schematic Supplementary Fig. 2) and used custom developed
scripts to design the primers for ampliﬁcation of the gene
replacement cassettes (see the Methods section). Cassettes were
successfully ampliﬁed for all 495 of the TFs, and were used to
transform MFIG001, a Δku80, pyrG+ strain derived from FGSC
strain A116030. We isolated null homokaryons for 97.7% (484)
transcription factor genes as deﬁned by our ability to isolate
strains, in which we could amplify from the hygromycin
resistance cassette to a region beyond the gene replacement
cassette in addition to a lack of a PCR product corresponding to
the target gene (see schematic Supplementary Fig. 2). Precise
replacement was further conﬁrmed for a randomly selected subset
of 12 mutants by Southern blot analysis (Supplementary Data 1).
Despite several attempts (minimum n= 3), we were unable to
isolate null mutants for 11 genes (Supplementary Data 1). The
majority of these genes encode components of the RNA
polymerase I/II/III transcription factor complexes, or are
transcription factors, which locate at a higher-level of a regulatory
hierarchy31 whose deletion would likely to cause a lethal
phenotype.
An azole susceptibility screen of the transcription factor
mutant library. The minimum inhibitory concentrations (MIC)
of itraconazole for the isogenic strain (MFIG001) was deter-
mined to be 0.5 mg/L in the RPMI-1640 media, following
procedures outlined by EUCAST32. To identify novel tran-
scriptional regulators associated with azole sensitivity and
resistance, we screened the transcription factor null library at
itraconazole concentrations representing sub-minimum inhibi-
tory concentrations (MIC) (0.06 and 0.12 mg/L) and at the MIC
(0.5 mg/L).
Six transcription factor null mutants exhibited clear and
reproducible ﬁtness defects in sub-MIC levels of itraconazole
when compared with the cohort of mutants in the collection
(Fig. 1a). The transcription factors knocked out in two of these
mutants have previously been deﬁned as activators of the
ergosterol biosynthetic pathway, including cyp51A, namely SrbA
and AtrR. The other null mutants identiﬁed in the screen lacked
the carbon catabolite repressor CreA33, the calcium-responsive
regulator ZipD34, the SAGA complex subunit AdaB35 and the
orthologue of the S. cerevisiae stress-responsive regulator GIS2
herein described as GisB36. When the library was screened at
itraconazole levels at the MIC, we identiﬁed six transcription
factor mutants, two of which we have previously described
(ΔhapX and ΔhapB)12 and four of which we associate with azole
resistance in A. fumigatus for the ﬁrst time (ΔnctA, ΔnctB, ΔareA
and ΔrscE).
We extended our phenotypic proﬁling of these isolates to assess
their general growth ﬁtness (Supplementary Fig. 3) and sensitivity
proﬁles to additional antifungal drugs (Fig. 1b, c). The identiﬁed
transcription factor null mutants showed variable growth ﬁtness
proﬁles, depending on the culture conditions tested. However, we
did not see a clear correlation between their growth ﬁtness and
azole-sensitivity phenotypes. In comparison with the isogenic
wild-type control, ΔcreA and ΔzipD showed increased sensitivity
to the ergosterol biosynthetic inhibitor terbinaﬁne. Interestingly,
the nctA and nctB null mutants phenocopied each other
(Supplementary Fig. 3) and were resistant to the triazoles
voriconazole (>32-fold increase in MIC) and posaconazole
(>128-fold increase), terbinaﬁne (twofold increase in MIC),
miltefosine (eightfold increase in MIC) and amphotericin B
(eightfold increase in MIC). Conversely, the nctA and nctB null
mutants showed hypersensitivity to the cell wall perturbing agents
Congo Red, Calcoﬂuor White, caspofungin and micafungin.
NctA and NctB are members of the CBF/NF-Y family of reg-
ulators. Pfam domain searches indicate that NctA and NctB are
members of the evolutionarily conserved CBF/NF-Y family of
transcription factors, which include the CBC transcription reg-
ulator complex (Supplementary Fig. 4)37. NctA (AFUB_029870)
encodes a 247 aa protein, and is a reciprocal BLAST match of the
S. cerevisiae negative cofactor 2 (NC2) complex α-subunit Bur6.
NctA and Bur6, however, show little sequence similarity with the
exception of the CBF/NFYB domain where they share 49%
identity over 75 contiguous amino acids. NctA has two para-
logues in A. fumigatus, HapE and an as yet un-named regulator
encoded by AFUB_058240. Consistent with the similar pheno-
types of the nctA and nctB null mutants, nctB (AFUB_045980)
encodes a 142 aa protein that is the reciprocal BLAST match of
the S. cerevisiae NC2 complex β-subunit (Ncb2) sharing 49%
sequence identity over 86% of the protein. NctB has one readily
identiﬁable paralogue in A. fumigatus, HapC.
Loss of NctA leads to a reduction in growth rate. To determine
if the effects of nctA loss were due solely to the gene replacement
and not other mutagenic events from transformation, an nctA
reconstituted strain was generated. The growth rate of the
nctA null alongside the parent strain MFIG001 (WT) and the
nctA reconstituted strain (nctA rec) was assessed on Aspergillus
complete media (ACM), Aspergillus minimal media (AMM),
RPMI-1640 and DMEM. In all conditions, the nctA null mutant
had a signiﬁcantly reduced growth rate (36–44% reduction)
compared with MFIG001 (Fig. 2a, b). Importantly, the recon-
stituted strain was indistinguishable in these assays from
MFIG001. This reduction in growth rate is associated with a
decrease in the initial rate of germination (5–6 h) and hyphal
extension (Fig. 2c, d).
NctA and NctB co-operatively regulate the same network of
genes. To assess the role of NctA and NctB on global regulation
of gene expression in A. fumigatus, we carried out transcriptomic
analysis (RNA-seq) using RNA extracted from cultures grown in
the RPMI-1640 media. In the absence of itraconazole, 1244 genes
were upregulated (>2-fold; FDR < 0.05) and 1049 (>2-fold; FDR
< 0.05) genes were downregulated in the nctA null when com-
pared with the isogenic parent strain (Supplementary Data 2).
Similarly, 1183 genes were upregulated and 1104 genes were
downregulated in the nctB null mutant. In the presence of itra-
conazole, 735 genes were upregulated and 736 genes were
downregulated in the nctA null mutant, and 865 genes were
upregulated and 852 genes were downregulated in the nctB null
mutant. Direct comparison of the two data sets shows that the
regulons of both transcription factors have a very high degree of
similarity in both conditions (Fig. 3a, b), suggesting that both
transcription factors work co-operatively.
To assess if NctA physically interacts with NctB, and to
determine if any other proteins are found complexed with NctA,
we generated a strain which encoded a functional C-terminally S-
tagged derivative of NctA (as shown by the fact that the strain that
was indistinguishable from the wild-type isolate) (NctA-S-tag, see
Supplementary Fig. 5), and performed co-immunoprecipitation
followed by LC/MS identiﬁcation of interacting proteins. In
addition to NctA, 20 unique proteins were identiﬁed (Supple-
mentary Table 1; >2 matched peptides), including NctB, the TBP-
associated transcriptional regulator Mot1, the transcriptional
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co-repressor Cyc8 and 9 ribosomal or ribosome-associated
proteins. The interaction between NctA and NctB and Mot1
was supported with reciprocal co-immunoprecipitation using a C-
terminally S-tagged version of NctB (NctB-S-tag, see Supplemen-
tary Fig. 5 and Supplementary Table 1). Taken together these data
suggest that, consistent with the role of Bur6 and Ncb2 in
yeast38,39, NctA and NctB form a complex with the TBP-
associated co-regulator Mot1 in A. fumigatus and are responsible
for regulating the same cohort of genes.
The NCT complex is a global regulator of sterol biosynthesis.
The negative cofactor complex has been deﬁned as a general
a
0.06 mg/L Itraconazole
–10 –5 0 5
0.12 mg/L Itraconazole
0.5 mg/L Itraconazole
Log2 relative fitness
ΔatrRΔsrbAΔcreA ΔzipD
ΔhapB
ΔnctA
ΔnctB
ΔhapX
ΔadaB ΔgisB
ΔareA
ΔrscE
b
16 8 4 2 1 0.5 0.25 0.125 0.063 0.031 0.016
WT
ΔsrbA
ΔatrR
ΔcreA
ΔzipD
WT
ΔsrbA
ΔatrR
ΔcreA
ΔzipD
ΔadaB
ΔgisB
ΔhapB
ΔhapX
ΔareA
ΔrscE
ΔnctA
ΔnctB
ΔhapB
ΔhapX
ΔnctA
ΔnctB
ΔnctA
ΔnctB
WT
ΔsrbA
ΔatrR
ΔcreA
ΔzipD
ΔadaB
ΔgisB
ΔhapB
ΔhapX
ΔareA
ΔrscE
ΔnctA
ΔnctB
ΔnctA
ΔnctB
Itraconazole
MIC (mg/L)
50 25 12.5 6.25 3.13 1.56 0.781 0.391 0.195 0.098 0.049
Miltefosine
MIC (mg/L)
16
0 0.2 0.4 0.6 0.8 1.0
0 0.2 0.4 0.6 0.8 1.0
8 4 2 1 0.5 0.25 0.125 0.063 0.031 0.016
WT
ΔnctA
ΔnctB
WT
ΔnctA
ΔnctA rec
WT
Posaconazole
MIC (mg/L)
50 25 12.5 6.25 3.13 1.56 0.781 0.391 0.195 0.098 0.049
Terbinafine
MIC (mg/L)
16 8 4 2 1 0.5 0.25 0.125 0.063 0.031 0.016
Amphotericin B
MIC (mg/L)
16 8 4 2 1 0.5 0.25 0.125 0.063 0.031 0.016
WT
ΔnctA
ΔnctB
WT
ΔnctA
ΔnctB
WT
Voriconazole
MIC (mg/L)
Relative growth 
c
Relative growth 
1600 800 400 200 100 50 25 12.5 6.25 3.125 1.56
Congo Red
MIC (mg/L)
16 8 4 2 1 0.5 0.25 0.125 0.063 0.031 0.016
Caspofungin
MIC (mg/L)
1600 800 400 200 100 50 25 12.5 6.25 3.125 1.56
Calcofluor White
MIC (mg/L)
16 8 4 2 1 0.5 0.25 0.125 0.063 0.031 0.016
WT
ΔnctA
ΔnctA rec
Micafungin
MIC (mg/L)
Fig. 1 Identiﬁcation of transcription factors associated with azole tolerance in A. fumigatus. a Relative growth ﬁtness of the 484 constructed TFKO
mutants in MIC (0.5 mg/L) and sub-MIC (0.06 and 0.12 mg/L) levels of itraconazole. Each dot represents the mean of three replicate experiments. The
TFKOs which exhibited signiﬁcant ﬁtness defects (ﬁtness less than −4 for sub-MIC, and more than 1.5 for MIC condition) are indicated by coloured circles.
b, c Heatmaps showing drug susceptibility proﬁles of the screened TFKO mutants to different antifungal drugs. Susceptibility assays were performed in
triplicate, where optical density readings of fungal growth were standardised to no-drug control wells and shown as a relative growth values. Source data
are provided as a Source Data ﬁle.
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regulator of transcription, however, it is clear from the data
presented in Fig. 3 that the NctA/B complex is responsible for
regulating only a subset of genes at any one time. To assess if
these subsets of genes are enriched for particular processes or
biochemical pathways, GO term and Metabolic Pathway
Enrichment analysis was performed on genes dysregulated more
than twofold. Such analysis are somewhat limited when applied to
A. fumigatus as GO terms and metabolic maps for ﬁlamentous
fungi are poorly deﬁned, however, we were able to identify
enriched classes of genes in our upregulated cohort that are
associated with secondary metabolism, transcriptional and
translational processing, transport and notably steroid biosynth-
esis (Supplementary Fig. 6).
As both nctA and nctB null mutants are pan-azole resistant and
our metabolic enrichment analysis identiﬁed steroid biosynthesis
as an enriched class in genes upregulated in the null mutants, we
assessed the mRNA levels of the genes in the ergosterol
biosynthetic pathway (Fig. 3c, d)40. Of the 29 genes annotated
as being associated with the pathway, 7 (erg13A, hmg2, erg12,
erg11A, erg24A, erg6 and erg2) have increased mRNA levels more
than 1.5-fold in the nctA null mutant (Fig. 3; Supplementary
Data 2), while nine have reduced mRNA levels (erg10A, erg13B,
erg7C, erg24B, erg25A, erg26B, erg27, smt1 and erg5). Intriguingly
for three of the downregulated genes, their paralogues are
upregulated (erg13B, erg24B, smt1 [paralog to erg6]). Notably,
erg7C has recently been identiﬁed as an oxidosqualene:proto-
stadienol cyclase which diverts 2,3-epoxysqualene from ergosterol
biosynthesis into the helvoic acid biosynthetic pathway41.
Potentially, reduced levels of erg7C would result in increased
ﬂux through the ergosterol biosynthetic pathway. Similarly, we
observed signiﬁcant downregulation of several siderophore
biosynthesis genes in the nctA and the nctB null mutants,
especially sidI, which acts to divert the ergosterol precursor
mevalonate into the siderophore biosynthesis pathway42 (Supple-
mentary Data 2). Together with the upregulation of hmg2 and
erg12 in the NCT mutants, this might suggest a potential role of
the NCT complex in balancing ergosterol and siderophore
biosynthesis.
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Fig. 2 Impact of nctA deletion upon A. fumigatus growth. a Colonial growth phenotypes of the wild-type MFIG001 (WT), the nctA null (ΔnctA) and the
nctA reconstituted strain (nctA rec) grown on a solid Aspergillus complete medium (ACM) for 72 h at 37 °C. b Radial growth phenotypes on solid ACM,
Aspergillus minimal medium (AMM), RPMI-1640 and DMEM. The error bars represent standard error of the mean of three independent experiments.
c Germination rates in liquid RPMI-1640 at 37 °C. P-value was calculated by repeated measures two-way ANOVA with Sidaks correction: ****P < 0.0001;
NS, P > 0.05. The error bars signify the standard deviations. d Hyphal extension rates in RPMI-1640 at 37 °C. P-value was calculated by Kruskal–Wallis test
with Dunn’s correction: ****P < 0.0001; NS, P > 0.05. Percentages of germination rates and hyphal extension rates were measured under the microscope.
The error bars represent standard error of the mean. Source data are provided as a Source Data ﬁle.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-14191-1 ARTICLE
NATURE COMMUNICATIONS |          (2020) 11:427 | https://doi.org/10.1038/s41467-019-14191-1 | www.nature.com/naturecommunications 5
Our RNA-seq analysis indicates that the NCT complex is a key
regulator of other transcription factors associated with azole
resistance. Loss of nctA leads to upregulation of activators of the
ergosterol biosynthetic pathway (2.2-fold for srbA and 1.6-fold for
atrR in the no-drug conditions) and downregulation of the
negative regulator-encoding gene hapC (approximately twofold,
Supplementary Data 2). These results suggest that the NCT
complex affects transcript levels of ergosterol biosynthesis genes
both directly and indirectly by modulating the expression levels of
these transcription factors.
NCT binds the promoters of genes linked to azole suscept-
ibility. To identify the promoters of genes that are directly
bound by the NCT complex, we performed chromatin-
immunoprecipitation sequencing (ChIP-seq) using an anti-S-tag
polyclonal antibody to isolate DNA bound to the NctA-S-tag
fusion protein in vivo.
We identiﬁed 4811 and 4290 NctA-binding peak regions in the
absence and the presence (0.5 mg/L) of itraconazole, respectively
(q-value < 0.01, fold enrichment >1.5; Supplementary Data 3). A
comparison of the ChIP-seq data sets showed that >70% of the
peak regions are common between the conditions (Fig. 4a).
Analysis of genome-wide occupancy of NctA revealed that the
large majority (~70%) of NctA-binding peaks are located within
1.5 kb upstream of the translational start site (TSS) of an
annotated gene (Fig. 4b). In total, 33.1% (3316 genes in no-drug
conditions) and 29% (2945 genes in 0.5 mg/L itraconazole
conditions) of the total predicted ORFs were assigned to have
at least one NctA-binding event within their upstream region.
Frequency distribution of NctA-binding peak summits showed
that NctA is predominantly positioned around 300 bp upstream
from the TSS (Fig. 4b). Applying the Multiple Em for Motif
Elicitation (MEME) de novo motif discovery program43, we
identiﬁed several conserved nucleotide motifs within the ChIP
peak regions (Fig. 4c). TATA-box like AT-rich motives were
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identiﬁed as the common nucleotide motifs with the highest e-
value. This is consistent with the result from previous studies with
NCT orthologues, which have been shown to form a stable
complex with the TATA-box-binding protein (TBP)44–47. The
results of the motif discovery suggest that the NCT complex in A.
fumigatus also interacts with TBP to regulate gene expression as
also suggested by the physical interaction studies.
We investigated the correlation between NctA occupancy and
mRNA levels by comparing the ChIP-seq and the RNA-seq data
sets. We expected that regulation of genes in close proximity to
the NctA-binding sites would be altered upon loss of nctA.
However, for the total 3361 genes having at least one NctA-
binding peak within 1.5 kbp of upstream region, only 755 genes
(22%) showed differential mRNA levels, and the remaining 2606
genes exhibited no signiﬁcant change (Supplemental Fig. 7a, b).
Among the 755 differentially expressed genes, 352 genes were
upregulated and 403 genes were downregulated in the nctA null
mutant in no-drug conditions. Similar results were obtained for
the itraconazole-treated (0.5 mg/L) sample (Supplemental Fig. 7c,
d). These results suggest that binding of the NCT complex alone
is not sufﬁcient for it to elicit its regulatory function.
In order to obtain further insight into the molecular mechan-
isms driving the itraconazole resistance in the nctA and the nctB
null mutants, we analysed binding of NctA on the promoter region
of the genes related to ergosterol biosynthesis and their known
transcriptional regulators (Supplementary Data 2, Supplementary
Fig. 8a). Of the 16 genes, which showed differential expression in
the RNA-seq analysis in the absence of itraconazole, nine genes
(erg10A, erg13B, erg11A, erg24A, erg25A, erg27, erg6, smt1 and
erg5A) were found to have at least one NctA-binding peak within
1.5 kb of the upstream region. Similarly, among the 14
differentially expressed genes in the presence of itraconazole, 11
genes were shown to have the peak regions within the deﬁned
upstream region (erg10A, erg13A, erg13B, erg11A, erg11B, erg24A,
erg24B, erg25B, erg6, smt1 and erg3). Interestingly, the genes
encoding the regulatory proteins HapC, SrbA and AtrR, and Mot1
were also conﬁrmed to have an NctA-binding peak in their
upstream region (Supplementary Fig. 8b, Supplementary Data 2).
Ergosterol levels are elevated in NCT complex mutants. To
analyse the effect of the loss of the NCT complex on ergosterol
No-drug (4811) 
0.5 mg/L Itraconazole (4290)  
3387 1415 879 
ATG
ATG
Total 3273 peaks
Total 2868 peaks
a
b
No-drug
Consensus motif E- value Frequency
TATAWAW 4.0e-012 115/1069
CCAATSA 4.1e-009 110/1064
CGGARTA 1.7e-005 61/1064
CACGTGAY 2.5e-004 40/1064
AGMCWA 1.9e-004 263/1064
GMGTCA 3.1e-003 125/1064
CCACY 1.7e-002 479/1064
c
0.5 mg/L itraconazole
Consensus motif E- value Frequency
ATATAWA 1.4e-010 68/869
GCCAAK 2.1e-008 202/869
ACGTGAYW 2.8e-005 30/869
CTCYGTA 1.8e-004 50/869
RCGCTA 8.6e-003 94/869
TATWTA 4.1e-002 78/869
–1500 –1000 –500 0
–1500 –1000 –500 0
0
100
200
300
Distance between the peak centre and nearest TSS (bp)
N
um
be
r 
of
 p
ea
ks
0
100
200
300
N
um
be
r 
of
 p
ea
ks
No-drug
Distance between the peak centre and nearest TSS (bp)
0.5 mg/L itraconazole
Logo
Logo
1 2
2
1B
its
0
2
1B
its
0
2
1B
its
0
2
1B
its
0
2
1B
its
0
2
1B
its
0
2
1B
its
0
3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6 7
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5
1 2 3 4 5
6
7
2
1B
its
0
2
1B
its
0
2
1B
its
0
2
1B
its
0
2
1B
its
0
2
1B
its
0
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6 7
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
7
8
7
8
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biosynthesis, sterol levels were quantiﬁed using GC–MS. Con-
sistent with our hypothesis, we observed a 60% increase in
ergosterol content (w/w) in both mutant strains when com-
pared with the isogenic control (P < 0.04; Fig. 5). Ergosterol
levels in the reconstituted strain were indistinguishable from
the wild-type (P > 0.85), and lower than observed in the
knockout (P= 0.0138). Taken together, our data suggest that
NctA and NctB are negative regulators of ergosterol biosynth-
esis via their interaction at the promoters of cyp51A and other
genes that encode components of the ergosterol biosynthetic
pathway.
Levels of the azole transporter CDR1B are elevated in NCT
mutants. The relatively modest increase in expression of cyp51A
(ca. 2.5-fold) and cellular ergosterol content (ca. 1.6-fold) in the
nctA mutant did not appear consistent with the relatively large
increase in itraconazole resistance (>64-fold), suggesting that
factors independent of ergosterol biosynthesis may be inﬂuencing
azole resistance in the NCT complex-deﬁcient strains.
Recently, an association between azole resistance and increase
in mRNA levels of the ABC transporter CDR1B has been
described30, and the transcriptional regulator AtrR has been
shown to co-regulate both cdr1B and cyp51A expression11. We
therefore examined our RNA-seq data to see if cdr1B was
dysregulated in the nctA and nctB null mutants. mRNA levels of
cdr1B were increased by 3.1 (FDR= 2.5 × 102) and 2.1 (FDR=
0.15)-fold, respectively, in the nctA and the nctB null (Fig. 6a).
Furthermore, evaluation of our ChIP-seq data suggested that this
regulation was related to a direct interaction between the NCT
complex and the cdr1B promoter (Fig. 6b). To assess if this
increase in transcript levels led to a concomitant increase in
translated protein levels, we quantiﬁed levels of the transporter
using an anti-CDR1B antibody48. In keeping with our transcrip-
tomic results, CDR1B levels were increased in the nctA null
mutant by >2.4-fold (Fig. 6c, d).
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The nctA null mutant shows enhanced immunogenic proper-
ties. Given the requirement of the NCT complex in the resistance
to two leading classes of therapeutic agents used to treat asper-
gillosis, it was important to assess if NCT complex-mediated
regulation is important for pathogenicity of A. fumigatus. As our
evidence to data suggests that the roles of NctA and NctB are
non-redundant with respect to each other, we investigated
pathogenic properties of the nctA mutants using both in vitro and
in vivo infection models.
To assess contact-mediated cytotoxicity, the nctA null mutant
was co-cultured with human A549 alveolar epithelial cells and the
murine macrophage RAW 264.7 cell line (Fig. 7a, b). Our results
indicate that loss of NCT complex results in a signiﬁcant
reduction in cell damage when compared with either isogenic
control or the reconstituted isolate. This result is consistent with
the growth reduction seen for this strain in the media used for
this experiment (Fig. 2b; Supplementary Fig. 5c). We next
examined immunogenic properties of the nctA null mutants to
mammalian immune cells. Murine macrophages challenged with
live spores from the nctA mutant showed an increase in
production of TNF-α, IL-6 and IL12p40 (Fig. 7c–e), whereas
human epithelial cells challenged with the nctA mutant showed
an increase in production of IL-8 (Fig. 7f). The nctA null mutant
also resulted in more activation of dendritic cells compared with
the wild-type (Fig. 7g, h). These ﬁndings suggest that the nctA
null mutant could potentially cause an aberrant immunogenic
response during infection. The increased immunogenic properties
observed for the nctA null mutant could be associated with an
alteration in the cell wall structure or spore surface, as the null
mutant was hypersensitive to the cell wall synthesis inhibitory
drugs and the perturbing agents Congo Red and Calcoﬂuor White
(Fig. 1c). However, examination by TEM revealed that the
thickness of the cell wall was unchanged in the nctA null mutant
(Supplementary Fig. 9).
An NCT mutant is virulent in a model of invasive aspergillosis.
To assess the impact of the loss of the NCT complex in
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Fig. 7 Cytotoxicity and immunogenic properties of the nctA null mutant. a, b A549 epithelial cells or macrophages were infected with the wild-type
(WT), the nctA null mutant (ΔnctA) or the nctA reconstituted isolate (nctA rec) for 24 h. Cytotoxicity of each mutant was evaluated by measuring the
release of lactate dehydrogenase (LDH) activity into the culture medium. The data represent ﬁve different infection challenges with triplicate LDH activity
measurements. Data are shown in fold change of LDH activity relative to the wild-type-infected cells. The error bars mean the standard error of the mean
(SEM), and P-values were calculated by Kruskal–Wallis test with Dunn’s correction: *P < 0.0180; **P < 0.0056 (for a, A549 cells). **P < 0.0032; ***P <
0.0007 (for b, macrophages). c–f Granulocyte macrophage colony-stimulating factor-induced bone marrow-derived dendritic cells (gm-csf BMDCs) were
infected with the A. fumigatus strains with the multiplicity of infection (MOI)= 5:1. Proinﬂammatory cytokines were quantiﬁed by ELISA. Data represent
three biological replicates (c–e) or ﬁve biological replicates (f) with ± SEM. P-values were calculated by ANOVA with Tukey’s correction: ***P < 0.002;
****P < 0.0001. g, h Activation of dendritic cells measured by CD40 and CD80 markers by ﬂow cytometry. Data represent three biological replicates with
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pathogenicity, we compared the virulence of the nctA null mutant
with that of the isogenic isolate MFIG001 in a leukopenic model
of invasive aspergillosis. All mice challenged with the
MFIG001 strain succumbed to infection (100% mortality) within
7 days post infection. Despite the signiﬁcant growth defect
(Fig. 2b) and the reduced cytotoxicity (Fig. 7a, b) observed in
NCT mutants, the virulence of the nctA null mutant was statis-
tically indistinguishable from the isogenic isolate (Fig. 8a).
In the leukopenic aspergillosis model, the host cellular innate
response is quantitatively attenuated particularly during the
initiation of infection allowing the microbe to proliferate and
cause host damage. Thus, we investigated the role of the NCT
complex in virulence in a murine model that uses cortisone
acetate as an immunosuppressive agent resulting in qualitative
defects in innate immunity. This model has been shown to better
reﬂect the host’s immune response in relation to detection of
fungal-speciﬁc PAMPs. In this model, overall murine mortality
with the isogenic strain was 45% at day 10 post infection.
Similarly, the nctA null mutant also showed 50% mortality at the
end of the infection time course. Although the nctA rec strain
showed a slightly increased mortality compared with the other
strains, no signiﬁcant differences were observed in virulence
between the all tested strains (Fig. 8b).
One potential hypothesis that could explain the retention of
virulence of the nctA null mutant is the aberrant immunogenic
properties observed in the mutant in vitro. However, no
signiﬁcant differences were observed in the expression levels of
cytokine-encoding genes (TNF-α, IL12 and IL-6) between the
strains at 36 h post inoculation (p.i.) (Fig. 8c). Furthermore, no
obvious difference in the inﬂammatory response was observed
between the strains in histopathology (Fig. 8d). Contrary to our
expectation from the in vitro studies, the nctA null mutant
showed an indistinguishable level of fungal burden with the
isogenic control at 36 h p.i. (Fig. 8e). These results suggest that
pathogenicity is maintained in this strain as its growth is not
signiﬁcantly altered in vivo, and our results add to the growing
body of evidence that poor in vitro growth is not an absolute
indicator of virulence defects49,50.
Discussion
In this study, we have constructed a 484 members transcription
factor null mutant library with the aim of providing a systematic
evaluation of regulators that contribute to azole resistance in
A. fumigatus. This library now provides an opportunity for the
fungal community to further explore regulatory mechanisms and
factors in the pathobiology of this important human fungal
pathogen. To date, much of our understanding of azole tolerance
has been driven by hypotheses derived from model organisms
that have signiﬁcantly superior functional genomic resources.
Functional screens of transcription factor null mutant libraries
have been performed in the model yeasts S. cerevisiae51 and
Schizosaccharomyces pombe52, the model ﬁlamentous fungus
Neurospora crassa53 and the pathogenic yeasts Cryptococcus
neoformans54 and Candida albicans55. Although these studies
have proven to be effective in uncovering a number key regulators
of drug resistance, the roles of transcription factors can vary
signiﬁcantly from species to species and large-scale transcrip-
tional rewiring is frequently observed (for a review see ref. 56). For
example, loss of the A. fumigatus pH-responsive transcriptional
regulator PacC, results in a >20-fold increase in ﬂucytosine sen-
sitivity in A. fumigatus57, however, loss of the orthologue in yeast
(RIM101) leads to an increase in ﬂucytosine resistance54,55. Our
screen of azole resistance in A. fumigatus highlights signiﬁcant
differences in the transcriptional regulation of azole tolerance in
ﬁlamentous fungi compared with yeasts. Of the 12 transcription
factors identiﬁed in our screen as having altered susceptibility to
itraconazole, only half HapB, SreA (SrbA)54, AdaB35,58, GisB59
CreA and HapX60 may have been predicted from previous
screening efforts. Of the remaining regulators, functional ortho-
logues of AreA exist in yeast (eg. Gat1p and Gln3p in S. cerevi-
siae), however, they have not been associated with changes in
azole resistance while orthologues of three (NctA, NctB and
RscE) are essential for viability, and two (ZipD and AtrR) are
absent in yeasts.
We have explored, in detail, the role of the two CBF/NF-Y
family transcription regulators, AFUB_029870 (NctA) and
AFUB_045980 (NctB) in azole resistance. The orthologues of these
regulators in S. cerevisiae, known, respectively, as Bur6 and Ncb2,
are subunits of a heterotrimeric transcriptional regulator called
Negative Cofactor 2 (NC2). The NC2 complex, originally identiﬁed
as a TBP (TATA-box-binding protein)-associated factor, acts as
a negative regulator of RNA polymerase II transcription by inhi-
biting formation of the pre-initiation complex (PIC)61,62. Assembly
of the heteromeric PIC is required for transcription from RNA pol
II-dependent promoters, and its assembly is contingent upon
recruitment of the TBP and the general transcription factors TFIIA
and TFIIB. NC2 inhibits PIC formation by preventing the
interaction of TBP with TFIIA and TFIIB [ref. 63 and references
therein]. The interaction between NCT and the TBP is regulated by
the Swi2/Snf2-type ATPase transcriptional modulator Mot164.
Consistent with a role for Mot1 in regulating NCT–TBP complex
binding, we have shown a direct physical interaction between Mot1
and NctA in A. fumigatus. Interestingly, it appears that the NCT
complex also has a direct role in negatively regulating Mot1 activity
as expression of mot1 is upregulated in the nctA null mutants and
binding sites for the NCT are found in the mot1 promoter (Sup-
plementary Data 2). In keeping with the role of the NCT as a
general transcriptional cofactor, genome-wide binding studies in S.
cerevisiae, C. albicans and H. sapiens have revealed interaction with
in excess of 20% of all RNA pol II gene promoters63–66. These
ﬁnding are consistent with our observation that NctA binds the
promoters of over 30% of protein encoding genes of A. fumigatus,
however, given this general role, what appears remarkable is that
nctA and nctB are not essential for viability of this fungus as they
are in yeasts44 and loss of function mutants have clear and very
speciﬁc phenotypic traits.
We have shown that loss of the NCT complex leads to a large
increase in MIC to the azoles, most notably for posaconazole
where we observed a shift in MIC from 0.25 mg/L to >16 mg/L.
This phenotype is associated with transcriptional dysregulation of
the ergosterol biosynthetic pathway directly and indirectly via
srbA10, atrR11,15 and hapC12, an increase in cellular ergosterol
levels (c. 1.6-fold) and an increase in levels of the Cdr1B azole
transporter (2.4-fold) (see model in Fig. 9). Although the increase
in sterol levels in the NCT mutants is rather modest and
apparently out of keeping with the large increase in MIC, recent
evidence does not support a direct linear relationship between
ergosterol levels and azole tolerance. Rybak et al. described
mutation in the sterol sensing domain of hmg1 (hmg1F262del) that
results in an apparent de-repression of ergosterol biosynthesis
leading to a modest increase (1.6-fold) in ergosterol levels, but a
much higher relative increase in MIC to itraconazole and isavu-
conazole (eight-fold)67. The reason for this incongruity is unclear,
however, studies in S. cerevisiae have highlighted that changes in
the composition of the plasma membrane affect the function of
transporters. For example, depletion in sterol levels caused by loss
of erg4 or erg6 leads to a reduction in the activity of the multi-
drug-resistance transporter Pdr568, and ergosterol is required to
correctly localise the azole exporter Cdr1p in C. albicans69. This
leads us to speculate that even relatively small increases in
ergosterol content in the cell membrane may lead to large
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increases in azole resistance via an indirect effect on azole
transporter levels. Given the pleiotropic nature of the NCT
complex, we cannot exclude that further factors may be con-
tributing to the high levels of azole resistance evident in the nctA
and nctB null mutants especially in light of our evidence showing
that they are hypersensitive to the cell wall acting agents, and
recent data showing a link between reductions in β-1,3-glucan
synthesis and the delayed fungicidal effects of voriconazole70.
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Fig. 8 Assessing the effect of loss of nctA on the virulence of A. fumigatus in murine infection models.Mice were infected with the wild-type (WT), the
nctA null mutant (ΔnctA) or the reconstituted isolate (nctA rec). a, b Kaplan–Meier curve for murine survival for mice treated via (a) intranasal infection
with 5.0 × 105 conidia after mice were rendered neutropenic by treatment with cyclophosphamide, and (b) intranasal infection with 7.0 × 106 conidia after
cortisone acetate treatment. A log rank analysis was used to compare the results between the strains. c Relative expression levels of proinﬂammatory
cytokines in the infected lung tissues. Data represent the mean of biological triplicates and error bars illustrate the standard deviation. Statistical
signiﬁcance was calculated by Student’s t test. d Histopathology of representative sections of lungs after 36 h post infection with WT, ΔnctA, or nctA rec.
Lung sections were stained with haematoxylin–eosin (H&E) for visualisation of the host cells, and Grocott’s Methenamine Silver (GMS) for visualisation of
the fungal elements. Scale bar: 50 µm. e Quantiﬁcation of the fungal burden in the infected lungs. The total genomic DNA was extracted from the same
lung lobe samples used for the cytokine expression analysis, and fungal DNA concentration was determined by qPCR. Data represent the means of
biological replicates, and the error bars mean standard deviation. The statistical signiﬁcance of variances between fungal burdens was calculated by using a
non-parametric Mann–Whitney t test. Source data are provided as a Source Data ﬁle.
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The most striking phenotypes that we have observed for the
nctA and the nctB null mutants aside from the resistance to the
azole class of antifungals is their resistance to the salvage ther-
apeutic amphotericin B and terbinaﬁne, which can be used in
the management of patients with chronic or allergic disease19.
Cross-resistance to the azoles and terbinaﬁne is understandable, as
both act on the ergosterol biosynthetic pathway (terbinaﬁne,
inhibits the action of squalene epoxidase, an enzyme that catalyses
the conversion of squalene to squalene 2,3-epoxide in the ergos-
terol biosynthesis pathway71). Cross-resistance between these
agents and amphotericin B is much harder to explain. Ampho-
tericin B acts by selectively binding ergosterol in the fungal
membrane and creating pores resulting in leakage of intracellular
contents72. Theoretically therefore, resistance to the azoles caused
by upregulation of ergosterol in the cell membrane should lead to
increased sensitivity to amphotericin B as this would enhance the
interaction between the drug and its binding target. Indeed, this
inverse correlation in resistance proﬁles has been observed in
several mutants from C. neoformans54 and in ergosterol biosyn-
thetic mutants of S. cerevisiae73. Cross-resistance to the azoles and
amphotericin B has previously been reported in artiﬁcially con-
structed yeast mutants. In C. albicans, laboratory generated strains
lacking both copies of ERG11 (Cyp51A orthologue) or ERG3
(sterol 5,6, desaturase) are viable and resistant to ﬂuconazole.
As ergosterol is replaced in their cell membrane by alternative
sterols, these isolates are also resistant to amphotericin B74,75.
However, depletion of ergosterol levels is clearly not the key cause
of amphotericin B resistance in the NCT mutants, as they exhibit
an increase in ergosterol content in line with the observed
increased expression of cyp51A and other genes of the ergosterol
biosynthetic pathway. There is limited information on the
mechanisms of amphotericin B resistance in A. fumigatus, how-
ever, it has been suggested that an increase in the production of
oxidative stress-reducing enzymes such as catalases that confers
resistance to the oxidising abilities of amphotericin B may con-
tribute to resistance75. It is also possible that changes in the
structure of the cell wall architecture in the nctA/nctB null strains
is contributing to amphotericin B resistance by limiting access to
the ergosterol in the cell membrane. Clearly, additional studies are
needed to further deﬁne the mechanism of amphotericin resis-
tance in these strains. Our results gain greater signiﬁcance as we
have observed that, despite signiﬁcant growth defects in vitro, the
nctA mutant retained similar levels of virulence and growth in
murine models of infection. This suggests that resistance observed
in the nctA/B null mutants may be clinically relevant, however, as
relatively few sequenced A. fumigatus isolates are in the public
domain, a genetic association between drug resistance and poly-
morphisms in nctA and nctB is currently difﬁcult to prove.
Clinical guidelines currently suggest that amphotericin B may be
used as a salvage therapeutic when initial therapy with vor-
iconazole fails18. This would clearly be contraindicated in an
infection with a strain with NctA/NctB-mediated azole resistance,
so rapid detection of such isolates would support appropriate
alternative therapeutic treatment such as an echinocandin to
which these mutants are extremely sensitive (Fig. 1c).
The relevance of our ﬁndings for clinical drug resistance in
pathogenic yeasts is unclear. Downregulation of Bur6 and Ncb2, in
C. albicans leads to a modest increase in azole resistance, which has
been attributed to a slight (ca. 2-fold) increase in cdr1 expression44.
To our knowledge however there have been no reports of
amphotericin B resistance in these strains, and resistant clinical
isolates carrying mutations in Bur6 and Ncb2 have not been
reported. Critically, as both Ncb2 and Bur6 are essential for viability
in C. albicans, null mutants are unlikely to persist in a host setting44.
In summary, we have generated a library of transcription factor
null mutants in the fungal pathogen A. fumigatus. This library is
publically available and can be exploited by the research com-
munity to provide comprehensive insights into transcriptional
networks governing critical factors associated with the cell biol-
ogy, pathogenicity and allergenicity in this understudied aetio-
logical agent. Using this resource, we have identiﬁed the network
of regulators governing azole resistance and identiﬁed a novel
mechanism that, through a single genetic mutation, is able to
drive both high level pan-azole resistance and cross-resistance to
the salvage therapeutic amphotericin B and terbinaﬁne without
signiﬁcantly impacting virulence.
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Fig. 9 Proposed model highlighting the mechanistic basis of the azole resistance in the NCT complex. The NCT complex is a global regulator, which acts
as both a negative and a positive regulator of a wide range of gene regulation that includes secondary metabolism, cellular transport and sterol biosynthesis
as important targets for virulence and azole resistance in A. fumigatus. The NCT complex ﬁne-tunes expression of several genes in the ergosterol
biosynthesis pathway and the azole efﬂux pump encoding cdr1 by directly interacting with their core promoter region. The NCT complex also acts as a key
regulator of azole resistance by modulating the expression levels of the transcription factors associated with ergosterol biosynthesis and azole resistance;
transcriptional repression of the activator-encoding srbA and atrR genes, and activation of the negative regulator-encoding hapC gene. Therefore, the loss of
the NCT complex causes an increased level of cellular ergosterol content and an elevated production of Cdr1B that leads to a multi-drug-resistance
phenotype to the azoles as well as the salvage therapeutics amphotericin B and terbinaﬁne.
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Methods
In silico identiﬁcation of transcriptional factors. Putative transcription factors
were identiﬁed by through a combinatorial approach. Semantic searches using the
terms transcription factor, C6, C2H2, HLH, transcriptional regulator, zinc ﬁnger,
bZIP, CCAAT, CBF, MYB, DNA binding and TATA were performed to identify
genes annotated as transcription factors within databases at ENSEMBL fungi and
ASPGD. These were combined with genes annotated as transcription factors at the
DBD transcription factor database. Duplicates were removed and each gene was
manually curated to remove those lacking functional domains associated with
transcription factor function (as deemed by searches for PROSITE, SUPER-
FAMILY, SMART or CDD domains) or those that lack functional data indicating a
direct role in transactional regulation.
Generation and validation of transcription factor null mutants. The tran-
scription factor null mutant collection was generated in the A. fumigatus strain
MFIG001 (previously known as A1160 Δku80 pyrG+30). Gene replacement cas-
settes were generated using a fusion PCR approach (see Supplementary Fig. 2)29.
Brieﬂy, primers P1 and P2 were used to amplify around 1 kb of the 5′ ﬂank, while
P3 and P4 were used to amplify the 3′ ﬂank. Primers hph_F and hph_R were used
to amplify a 2.8 -kb hygromycin B phosphotransferase cassette from pAN7-1. PCR
products were puriﬁed by solid phase extraction with the Qiagen QIAquick® PCR
puriﬁcation kit (Qiagen). Fusion of the three products was facilitated by the pre-
sence of common linker sequences on primers P2 and hph_F, P3 and hph_R and
the use of the nested primers P5 and P6. PCR ampliﬁcation was carried out using
the protocols deﬁned by Szewczyk et al.29 Transformation was carried out as
previously reported30. The sequences of all primers used are given in Supple-
mentary Data 1.
Validation of homologous recombination and single integration of the deletion
cassette was performed by PCR (Supplementary Fig. 2). PhusionFlash High-
Fidelity Master mix (ThermoFisher Scientiﬁc) was used for all reactions. Primers
P1 with hph-chk 5′-Rv and hph-chk 3′-Fw with P4 were used to amplify a region
of about 1 kb from within the deletion cassette to the ﬂanking region outside of the
deletion cassette. Furthermore, PCR was performed with P1 and P4 as primers to
check the purity of the gene knockout strain.
Drug sensitivity screening. Conidia of 484 TFKO strains were inoculated in 25 -
mL culture ﬂasks containing ACM+ 100 µM hygromycin. Conidia were harvested
by ﬁltration and counted via optical density measurements. Approximately
2000 spores were inoculated per well of a CytoOne® 96-well plate (StarLab) con-
taining RPMI-1640 medium 2.0% glucose and 165 mM MOPS buffer (pH 7.0) with
0, 0.06, 0.12 or 0.5 mg/L itraconazole. Plates were incubated at 37 °C for 48 h (0,
0.06, 0.12 mg/L or 96 h (0.5 mg/L), and optical density measurements were taken at
600 nm. Fitness was calculated by normalising optical density to the wild-type
strain. Relative ﬁtness was obtained by normalising ﬁtness under itraconazole
challenge to ﬁtness of this strain under no itraconazole challenge. MIC determi-
nation for all drugs was carried out according to methods outlined by EUCAST32.
General growth ﬁtness of the transcription factor nul mutants in liquid RPMI-1640
medium was determined in the same microculture conditions (n= 3). Relative
ﬁtness was obtained by optical density measurements (OD600) normalised to the
wild-type strain.
Radial growth germination rate and hyphal extension analysis. Radial growth
of the wild-type strain (MFIG001), the nctA null mutant or the nctA reconstituted
strains was measured by inoculating 500 spores on Aspergillus Minimal Media
(AMM), Aspergillus Complete Media (ACM), RPMI-1640 medium with 2.0%
glucose and 165 mM MOPS buffer (pH 7.0) or Dulbecco’s Modiﬁed Eagle’s
Medium (DMEM) on petri dishes. Plates were incubated at 37 °C for 72 h, and the
radius of colonies was measured every 24 h.
Germination rate and hyphal extension rate were determined as follows. In
total, 500 µl of 5 × 105 spores of the strains were inoculated in the RPMI-1640
medium containing 2.0% glucose and 165 mM MOPS buffer (pH 7.0) in a 24-well
glass bottom plate. The culture was incubated at 37 °C, and either optical density
(600 nm) was measured on a Synergy 2 Multidetection Microplate reader (BioTek)
or images were taken on a Leica SP8X confocal microspoce (Leica). Sporulation
and hyphal length were measured in ImageJ.
S-tag co-immunoprecipitation. C-terminal S-tagged cassettes were generated by
fusion PCR using primers SP1-SP8 (Supplementary Data 1). Three separate PCR
reactions were performed for initial ampliﬁcation of the cassette components.
Primers SP1 and SP2 were used to amplify the 5′ ﬂank and TF coding sequence,
primers SP3 and SP4 ampliﬁed the downstream region of the TF (ca. 1 kb) from
MFIG001 genomic DNA. Primers SP5 and SP6 were used to amplify the S-Tag,
G5A linker and pyrG gene from pHL8176 PCR products were puriﬁed by solid
phase extraction with the QIAquick® PCR puriﬁcation kit (Qiagen). Fusion of the
three products was facilitated by the presence of linker sequences on primers SP2,
SP3, SP5 and SP6 and the use of nested primers SP7 and SP8. The cassette was
transformed into A. fumigatus A1160p- and NctA-S-tag and NctB-S-tag strains
were validated by PCR as described above for the gene KO process. Proteins were
extracted from 16 h shake ﬂask cultures (SAB medium, incubated at 37 °C). Brieﬂy,
biomass was frozen in liquid nitrogen and ground to a ﬁne powder before incu-
bation on ice in 6 ml of ice-cold HK buffer (100 mM NaCl) per 1 g biomass for 30
min. Samples were centrifuged at 7500 × g for 30 min, and ﬁltered through glass
wool to remove cellular debris. To purify the S-tagged proteins, crude protein
extract was incubated with S-protein agarose beads (Novagen) with gentle agitation
at 4 °C for 2 h. Samples were centrifuged, and the agarose bead pellet was washed in
ice-cold HK Buffer with 100 mM NaCl and transferred to a S-Protein spin column
(Novagen), where the beads were washed a further six times with 700 µl HK Buffer
with 100 mM NaCl. S-tagged proteins were eluted using 50 µl Laemmli sample
buffer. Eluted proteins were analysed by the Protein Mass Spectrometry at the
Biological Mass Spectrometry Core Facility at the University of Manchester.
Chromatin immunoprecipitation (ChIP) of S-tagged NctA. In total, 1 × 106
spores/ml of the wild-type strain (MFIG001) or the S-tagged NctA expressing
strain were grown in 50 ml of Vogel’s minimal medium for 18 h at 37 °C with
constant shaking at 180 rpm. The mycelia were harvested by ﬁltration, washed
twice with distilled water and were transferred into 50 ml of RPMI-1640 medium
(Sigma-Aldrich) containing 2.0% glucose and 165 mM MOPS buffer (pH 7.0). The
cells were incubated for 4 h in the absence and the presence (0.5 mg/L) of itraco-
nazole at 37 °C under shaking. Cross-linking was carried out by the addition of
formaldehyde to a ﬁnal concentration of 1.0% followed by incubation at 37 °C for
20 min. The cross-linked mycelia were ground to a ﬁne powder under liquid
nitrogen, and ~100 mg of the mycelial powder was suspended in 1.0 ml of ChIP
lysis buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100,
0.1% deoxycholate (Sigma D6750), 0.1% SDS, 1 mM PMSF and fungal proteinase
inhibitor cocktail (Sigma)). The cell suspension was then sonicated with a
Q125 sonicator (Qsonica, USA) to shear the chromatin to fragments with an
average size of 0.2–0.5 kbp. After sonication, the insoluble cell debris was pelleted
by centrifugation, and the soluble fraction was used for ChIP experiments and
input control preparations. ChIP reaction was performed with an Anti-S-tag
polyclonal antibody (ab18588, abcam) on Dynabeads Protein A magnetic beads
(ThermoFischerScientiﬁc). Immunoprecipitated DNA was reverse cross-linked,
treated with RNaseA (Sigma-Aldrich) and then puriﬁed using a MinElute PCR
puriﬁcation kit (Qiagen). To prepare input control, 100 µL of the sonicated extract
was reverse cross-linked, treated with RNaseA (Sigma-Aldrich) and then puriﬁed
using a MinElute PCR puriﬁcation kit (Qiagen).
ChIP-sequencing analysis. ChIP-seq libraries were constructed following the
manufacturers instructions for Illumina ChIP-seq library preparation. Eight sam-
ples were indexed and sequenced in a single lane on the Illumina HiSeq2500 as
paired-end reads.
Raw sequencing reads were quality controlled with Illumina chastity ﬁlter and
fastqc v0.11.3, and then Illumina adapters were trimmed from them using
Trimmomatic. The resulting reads were aligned to the A. fumigatus A1163 CADRE
genome from Ensemble fungi, version 26 using Bowtie2. Peak calling was carried
out using a Model-based Analysis for ChIP-Sequencing (MACS277) version 2.1.0
with a q-value cut-off of 0.01. The results reported herein are for the combined
reads from two biological replicate samples. All ChIP-seq experiments were carried
out in two biological replicate samples. All ChIP-seq data sets are deposited in the
NCBI Gene Expression Omnibus (GEO; https://www.ncbi.nlm.nih.gov/geo/) under
accession number GSE129967 in a GEO Superseries GSE133491.
Conserved motif discovery. The reproducible 100 bp of the merged ChIP peak
regions with more than twofold read enrichment compared to the corresponding
were analysed for conserved nucleotide motifs using the MEME suite78 version
4.12.0. DNA sequence of the ChIP peak regions was retrieved from the genomic
locations using the getfasta function from the BED tools suite79 and analysed with
the default setting.
Transcriptomic analysis. In total, 1 × 106 spores/ml of the wild-type (MFIG001),
the nctA null or the nctB null mutant was grown in 50 ml of Vogel’s minimal
medium containing 1.0% glucose for 18 h at 37 °C on a rotary shaker (180 rpm).
Mycelia were collected by ﬁltration, and washed twice with distilled water. About
1.0 g of wet mycelia were transferred into 50 ml of RPMI-1640 medium containing
2.0% glucose and 165 mM MOPS buffer (pH 7.0), and the cells were incubated for
4 h in the absence and the presence of itraconazole (0.5 mg/mL) at 37 °C with
shaking. The drug-treated mycelia were then collected by ﬁltration, immediately
frozen with liquid nitrogen and kept at −80 °C until use.
The total RNA was extracted using TRI Reagent® (Sigma-Aldrich) according to
the manufacture’s instructions. The extracted RNA samples were treated with RQ1
RNase-Free DNase (Promega) and further puriﬁed using the RNeasy Mini Kit
(Qiagen).
For paired-end RNA sequencing, libraries were generated using the TruSeq®
Stranded mRNA assay (Illumina, Inc.), according to the manufacturer’s
instructions. Eight samples were indexed and sequenced in a single lane on the
Illumina HiSeq2500. Generated Fastq ﬁles were analysed with FastQC, and any
low-quality reads were trimmed with Trimmomatic. All libraries were aligned to
the A. fumigatus A1163 genome assembly GCA_000150145.1) with the gene
annotation from CADRE/Ensembl Fungi v24 using Bowtie, and only matches with
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the best score were reported for each read. All RNA-seq experiments were carried
out in three biological replicates.
Differential expression analysis was performed using DESeq80.
All RNA-seq data sets are available in the NCBI Gene Expression Omnibus
under accession number GSE133464 in a GEO Superseries GSE133491.
Gene set enrichment analysis. Gene ontology, functional category and KEGG
pathway enrichment analysis were carried out using the FungiFun2 2.2.8 BETA81
web-based server (https://elbe.hki-jena.de/fungifun/fungifun.php) with the A.
fumigatus A1163 genome annotation. Differentially expressed genes showing more
than twofold enrichment with FDR < 0.05 were subjected to the enrichment ana-
lysis. Signiﬁcance level of the enrichment was analysed using the Benjamini-
Hochberg adjustment method with a P-value cut-off <0.05.
Sterol analysis. Conidia (1 × 106) were grown in 50 mL RPMI-1640, incubated for
24 h at 37 °C with shaking (200 rpm). Mycelia were harvested, freeze dried and dry
weights obtained prior to processing. Pellets were sonicated thoroughly (6 × 30 s
with Branson Digital Soniﬁer 250) in 1 ml of ddH2O, and an internal standard of
10 µg of cholesterol was added to each sample.
Sterols were extracted and derivatised as previously described82. Brieﬂy, lipids
were saponiﬁed using alcoholic KOH and non-saponiﬁable lipids extracted with
hexane. Samples were dried in a vacuum centrifuge and were derivatised by the
addition of 0.1 ml BSTFA TMCS (99:1, Sigma-Aldrich) and 0.3 ml anhydrous
pyridine (Sigma-Aldrich) and heating at 80 °C for 2 h. TMS-derivatised sterols
were analysed and identiﬁed using GC/MS (Thermo 1300 GC coupled to a Thermo
ISQ mass spectrometer, ThermoFischerScientiﬁc) and Xcalibur software
(ThermoFischerScientiﬁc). The retention times and fragmentation spectra for
known standards were used to identify sterols. The quantity of ergosterol (w/w)
was calculated using the peak areas of ergosterol and the cholesterol internal
standard from triplicate samples.
Western blotting of CDR1B. In total, 1 × 106 of A. fumigatus conidia were
inoculated in a petri dish containing 20 mL of Sabouraud dextrose broth at 37 °C
for 16 h. Mycelium that formed as a bioﬁlm on the top was collected (100 mg), and
was ground into ﬁne powder in liquid nitrogen using a mortar and pestle. The
ground mycelium was resuspended in 0.5 ml of 10% trichloroacetic acid (TCA),
thoroughly vortexed, incubated for 5 min at room temperature and then washed
three times in 90% acetone with 20 mM HCl and air dried. The TCA precipitate
was then extracted with 8M urea sample buffer (8 M urea, 5% SDS, 1% β-ME,
40 mM Tris-HCl (pH 8.0), with traces of bromophenol blue). Aliquots of this
suspension were electrophoresed by 10% SDS-PAGE and then transferred to a
nitrocellulose membrane. The membrane was blocked with 5% non-fat dry milk in
phosphate-buffered saline with 0.1% Tween 20, and then probed with a polyclonal
rabbit antiserum. The rabbit anti-CDR1B polyclonal antibody48 was used with a
horseradish peroxidase-conjugated secondary antibody (NA934V, GE Healthcare)
and a SuperSignal West Pico chemiluminescent substrate (ThermoFisher Scientiﬁc)
to visualise imunoreactive protein on an X-ray ﬁlm.
Murine infection models. The murine infection experiments were performed
under UK Home ofﬁce Project Licence PDF8402B7 and approved by the Uni-
versity of Manchester Ethics Committee.
A. fumigatus strains were cultured on ACM containing 5 mM ammonium
tartrate for 6 days at 37 °C, and conidia were harvested in sterile saline and used for
infection experiments.
CD1 male mice (Charles River UK, Ltd.) were housed in groups of 3–4 in IVC
cages with access to food and water ab libitum. All mice were given 2 g/L
neomycine sulphate in their drinking water throughout the course of the study. For
the leukopenic model of infection, mice were rendered leukopenic by
administration of cyclophosphamide (150 mg/kg of body weight; intraperitoneal)
on days −3, −1,+ 2 and every subsequent third day, and a single subcutaneous
dose of cortisone acetate (250 mg/kg) was administrated on day −1. For the
cortisone acetate model, mice were immunosuppressed with cortisone acetate (250
mg/kg), which were administrated subcutaneously on days −3, −1,+ 2 and every
subsequent third day. Mice were anaesthetised by exposure to 2–3% inhalational
isoﬂurane and infected by intranasally with a spore suspension of 1.25 × 107
conidia/ml (leukopenic model) or 1.75 × 108conidia/ml (cortisone acetate model)
in 40 µl of saline solution. Mice were weighed every 24 h from day −3, relative to
day of infection, and visual inspections were made twice daily. In the majority of
cases, the endpoint for survival in experimentation was a 20% reduction in body
weight measured from day of infection, at which point mice were killed.
Kaplan–Meier survival analysis was used to create a population survival curve and
to estimate survival over time, and p-values were calculated through a log rank
analysis.
Histology analysis. Immunosuppressed male CD1 mice (n= 3) were infected as
described above. After 36 h of infection, mice were killed and lungs were parti-
tioned into lobes destined for histology analysis or fungal burden and cytokine
mRNA expression analysis. Lobes for fungal burden and cytokine analysis were
snap-frozen in liquid nitrogen and stored at −80 °C until use. Lobes for histological
analysis were immediately ﬁxed in 4.0% (v/v) formaldehyde (Sigma-Aldrich), and
subsequently embedded in parafﬁn. Four-micrometer sections were stained with
haematoxylin–eosin (H&E) and Grocott’s Methenamine Silver (G.M.S). Images
were taken using a Pannoramic 250 Flash Slide Scanner (3D HISTECH) using
brightﬁeld illumination.
Fungal burden analysis. The total genomic DNA was extracted from the infected
lung samples using a standard CTAB DNA extraction method. Fungal burden was
determined by quantitative real-time PCR (qPCR) as described previously83. qPCR
was performed in a 7500 Fast Real-Time PCR system (Applied Biosystems) using
the SsoAdvanced Universal SYBR Green Supermix (Bio-Rad) with the primers
listed in the Supplementary Dataset 1. Ampliﬁcation reactions were performed in
triplicate in a ﬁnal volume of 20 µL using 0.5 µM forward primer, 0.5 µM reverse
primer and 100 ng of total DNA. qPCR data were analysed as described83. The
statistical signiﬁcance of variances between fungal burdens was calculated by using
a non-parametric Mann–Whitney t test.
Cytokine expression analysis. The total RNA was extracted from the infected
lung samples using the RNeasy kit (Qiagen). First-strand cDNA was synthesised
using the iScript cDNA synthesis kit (Bio-Rad) with 500 ng of the total RNA as a
template. Ampliﬁcation reactions were performed using the iTaq Universal SYBR
Green Supermix (Bio-Rad) in a ﬁnal volume of 20 µL using 0.5 µM forward primer,
0.5 µM reverse primer and 2 µL of ﬁvefold diluted cDNA. Primers used in this
analysis are listed in Supplementary Dataset 1. Relative expression level of gene
expression was analysed using the ΔΔCt method with the murine actin encoding
actB as the reference. Experiments were performed in biological triplicates. A two-
sided Student’s t test was used for statistical analysis, where P-value of <0.05 were
considered as signiﬁcant.
Cell toxicity assays. A549 human pulmonary carcinoma epithelial cells (Amer-
ican type culture collection, CCL-185) and Raw 264.7 macrophages were used
under passage 20. Cells were maintained at 37 °C, 5% CO2 in Dulbecco’s Modiﬁed
Eagle’s Medium (DMEM), 10% foetal bovine serum (FBS) and 1%
penicillin–streptomycin (Sigma-Aldrich). For all experiments, 2 × 105 A549 or
RAW 264.7 cells were seeded in 24-well plates and incubated for 16 h when
conﬂuence equals 90%. Cells were then challenged with 105 spores of ΔnctA, nctA
rec and the isogenic control and incubated for 24 h. Following co-incubation with
A. fumigatus spores, cell culture supernatants were collected, and the level of
inﬂammatory markers or cell toxicity via lactate dehydrogenase assay were mea-
sured (Promega).
The concentration of IL-8 and IL-6 were determined in A549 epithelial cells co-
cultured with A. fumigatus strains by using the Human IL-8/CXCL8 and IL-6
DuoSet ELISA according to the manufacturer’s instructions (R&D systems).
Experiments were performed in ﬁve biological replicates and technical triplicates.
For data analysis, a four-parameter logistic (4-PL) curve was created plotting the
absorbance versus Log10 concentration of the standards and then sample
concentrations determined by using a non-linear regression. Differences in IL-8
and IL-6 concentration between A549 cells challenged with ΔnctA, nctA rec and the
isogenic control spores and uninfected controls were determined by one-way
multiparametric ANOVA with Dunnet’s correction using GraphPad Prism 7.0 (La
Jolla, CA, USA).
BMDC culture. GM-CSF induced BMDCs were generated as previously descri-
bed84. Brieﬂy, bone marrow cells from C57BL/6 mice were seeded at 2 × 105/mL in
complete media (RPMI-1640 (Sigma) plus 20 ng/mL GM-CSF (Peprotech), 10%
FCS, 2 mM L-glutamine (Gibco), 100 U/mL penicillin 100 µg/mL streptomycin
(Sigma)). Cells were cultured for 10 days, with 50% of the media replaced on days
3, 6 and 8. On day 10, DCs were re-plated at 2 × 105 cells/well, with 10 × 105 A.
fumigatus spores (MOI 5:1), and incubated for 6 h at 37 °C.
Flow cytometry and ELISA. Post incubation, cells were taken for ﬂow cytometry,
and supernatants for ELISA. Cells were plated at 1 × 106 cells/well, washed twice in
PBS, and stained with Zombie UV (Biolegend). FcR block (Biolegend) was then
added, in addition to the following antibodies: CD11c-APCef780, CD40-PE CD80-
PerCP/Cy5.5 (all Biolegend). Cells were washed twice in ﬂow buffer (PBS 2 mM
EDTA (Sigma) 2% FCS (Sigma)), and samples were acquired on a BD Fortessa, and
analysed using Flowjo v10 (TreeStar). Cytokines for ELISA were measured using
puriﬁed coating, detection antibodies and standards (Biolegend) or duosets (R&D),
as per the manufacturers protocol.
TEM imaging. For transmission electron microscopy, the samples were ﬁxed with
4% formaldehyde+ 2.5% glutaraldehyde in 0.1 M HEPES buffer (pH 7.2). Then
samples were incubated in 1% sodium met-periodate (in H2O) for 1 h. After that
they were postﬁxed with 1% osmium tetroxide+ 1.5% potassium ferrocynaide in
0.1 M cacodylate buffer (pH 7.2) for 1 h and ﬁnally in 1% uranyl acetate in water
for 1 h. Specimens were dehydrated in ethanol series inﬁltrated with TAAB Low
Viscosity resin and polymerised for 24 h at 60 °C. Sections were cut with Reichert
Ultracut ultramicrotome and observed with FEI Tecnai 12 Biotwin microscope at
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100 kV accelerating voltage. Images were taken with Gatan Orius SC1000 CCD
camera.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All RNA-seq and ChIP-seq data sets are available in the NCBI Gene Expression Omnibus
(GEO) under accession number GSE133491. This GEO Superseries includes two
SubSeries for the RNA-seq dataset (GSE133464 and the ChIP-seq dataset [GSE129967].
A processed format of the RNA-seq and the ChIP-seq data sets is included in
Supplementary Data 2 (RNA-seq) and 3 (ChIP-seq). The source data underlying
Figs. 1a-c, 2b-d, 3a-b and d, 4b, 5, 6c-d, 7a-h, 8a-c and e, and Supplementary Figs 1a, b,
3c, 5c–e, 6a–d, and 9 are provided as a Source Data ﬁle.
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